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Chemistry or medicine 1958-1963? 
In the fifties, high school students in Germany 
had to select their career goals without much guid-
ance or college education. I was a student at a gym-
nasium of mathematics and natural sciences in Os-
terode, a provincial town near the Harz Mountains 
in Lower Saxony of Germany. My father, a general 
practitioner in a small town in the Harz, had differ-
ent ideas. He wanted me to be a medical student 
and ultimately take over his practice. The university 
town, Göttingen, was located 50 km from our home. 
Göttingen was then a small town, but medical edu-
cation was excellent and diverse. I stayed in a room 
near the Max Planck Institute where Otto Hahn, the 
Nobel laureate in nuclear fission, was still active. My 
inaugural dissertation involved measurements of 
nuclear sizes in rat liver, adrenals, and endometrium 
after the animals were treated with drugs affecting 
the autonomic nervous system (Koeppen, 1963). My 
interest in the neurosciences began during my last 
year of medical school. The inaugural dissertation 
received the annual faculty award in 1963; and the 
sum of 800 Deutschmarks was sufficient to defray 
my cost of a trip by ocean liner to the United States 
where a non-profit organization, the Ventnor Foun-
dation, had offered me a position as a medical assis-
tant (intern) at a New Jersey hospital. After an in-
ternship of 18 months, I joined the neurology train-
ing program at Montefiore Hospital and Medical 
Center in New York City in 1965. Neurology educa-
tion was disappointing, but I met the late Drs. Harry 
Zimmerman, Robert Terry, and Asao Hirano who 
stimulated my interest in neuropathology and, 
above all, clinicoanatomic correlation in neurology 
and neurosurgery. After one year at Montefiore, I 
was recruited to the Department of Neurology and 
Psychiatry of Northwestern University School of 
Medicine in Chicago. My first assignment was to the 
Veterans Affairs (VA) Medical Center in Hines, Illi-
nois, where the late Dr. Kevin D. Barron was the 
chief neurologist. Dr. Barron had been trained by 
Drs. Zimmerman and Terry and continued to prac-
tice neuropathology at Northwestern and the VA 
Medical Center. Dr. Barron was a master of clinico-
anatomic correlation and stressed that neurologists 
should have training in neuropathology. His training 
had a major impact on my further career as a neu-
rologist and neuropathologist. While opposition to 
neurologists and psychiatrists practicing neuropa-
thology was evolving, we were reminded of non-
pathologists who had made major contributions to 
the practice of neuropathology. We thought of Alois 
Alzheimer and his 1906 illustrations of neurofibril-
lary tangles, and of King Engel who gave us modified 
trichrome in the diagnosis of mitochondrial  
Reflections 
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Figure 1. Laboratory staff in Albany, NY. From left to right: Alyssa Sossei, research assistant; Sarah Bjork, medical student; R. Liane Ramirez, 
research assistant; the author; Pamela Kruger, post-doctoral scientist. 
 
 
myopathy. My training in neuropathology from 
1969 to 1971 was enough to gain acceptance to the 
neuropathology board examination in 1980, and, 
since that time, I was convinced that I was a better 
neurologist because I was also a neuropathologist. 
During my time in Chicago, Dr. Barron insisted that I 
should learn neurochemistry as well, and I was as-
signed to the research laboratory of the late Dr. Jo-
seph Bernsohn. Over a one-year period, I learnt 
standard and advanced laboratory techniques, and 
my initial interest in chemistry came to belated frui-
tion. Since joining the Department of Neurology at 
Albany Medical College in 1969, I have maintained a 
neurochemical and neuropathological laboratory at 
the Albany VA Medical Center (figure 1) while also 
running the clinical neurology service. Among my 
valued neurochemical discoveries was a sensitive as-
say of brain malonyl-coenzyme A, a critical molecule 
in the biosynthesis of fatty acids (Mitzen and Koep-
pen, 1984). The autopsy practice generated access 
to specimens from unusual cases, such as Pelizaeus-
Merzbacher disease (PMD). The neurochemical la-
boratory helped me identify the cause of the dis-
ease, namely, a deficiency of proteolipid protein 
(PLP) (Koeppen, et al., 1987). The mutation in this 
patient with PMD was a point mutation (Hudson, et 
al., 1989) though later, the mutation in most cases 
was identified as a duplication of the PLP gene. The 
PLP protein is unusual because it is soluble in a mix-
ture of chloroform and methanol (Folch and Lees, 
1951). Through the work on PMD, I met the co-dis-
coverers of PLP, the late Dr. Marjorie B. Lees (figure 
2), and the late Prof. Franz Seitelberger who had ad-
vanced the existence of a “connatal” form of PMD. 
Prof. Seitelberger invited me to the Neurological In-
stitute in Vienna where I gave a lecture on PLP and 
PMD. Profs. Kurt Jellinger and Herbert Budka were 
in audience. I also discovered that the late neuropa-
thologist, Dr. Wolfgang Zeman (figure 3), had writ-
ten to Dr. Lees in 1963, proposing that PLP was a 
likely candidate in the genetic mutation underlying 
the disease. Pelizaeus-Merzbacher disease is an X-
linked disorder, and Pelizaeus, a German balneolo-
gist, understood the mechanism of X-linked trans-
mission before the existence of an X-chromosome 
was known. Pelizaeus (1885) stated succinctly that 
the “disease goes through the mother but does not 
do anything to her”. It is peculiar that at the time of 
my work on PMD, a spontaneous X-linked central 
nervous system myelin deficiency in rats was discov-
ered in Albany, NY. The animal model was called 
"myelin-deficient (md) rat", and the neuropatho-
logic and genetic similarity to Pelizaeus-Merzbacher 
disease was remarkable (Koeppen et al, 1988). PMD 
patients also show a lack of other myelin proteins, 
and the injection of a white matter homogenate into  
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guinea pigs (type 13) did not cause experimental al-
lergic encephalomyelitis (EAE). Antibodies to PLP 
were not commercially available, and I isolated the 
protein from frozen normal human white matter. In-
jection into rabbits caused encephalitis that closely 
resembled EAE. One rabbit with advanced encepha-
litis generated a high-titer anti-PLP antibody that 
worked very well on paraffin sections of human cen-
tral nervous tissue. The antibody became very pop-
ular, and I forwarded samples to several foreign and 
domestic myelin investigators. 
 
 
Figure 2. Marjorie B. Lees 
 
A new goal: the hereditary ataxias 
In 1972, a patient with autosomal dominant 
ataxia presented with an unusual disturbance of oc-
ular motility that became known as supranuclear 
pseudoophthalmoplegia. Many years later, the mu-
tation was identified as a cytosine-adenine-guanine 
(CAG) trinucleotide repeat expansion on chromo-
some 12, and the disease was named spinocerebel-
lar ataxia type 2 (SCA-2). The mutation was like the 
CAG trinucleotide expansions in SCA-1 and SCA-3 
(Machado-Joseph disease). SCA-6, SCA-7, and SCA-
17 were later also identified as the consequence of  
 
Figure 3. Wolfgang Zeman 
 
CAG trinucleotide repeat expansions. The expan-
sions are expressed by changing the length of poly-
glutamine in the cognate proteins, hence, became 
known as polyglutamine (or polyQ) diseases. Anti-
bodies raised against the polyQ stretch of the nor-
mal TATA-binding protein, designated “1C2”, be-
came useful in the visualization of intranuclear inclu-
sion bodies in the ataxic polyQ diseases and Hun-
tington's chorea. Stimulated by the experience with 
a single patient with supranuclear pseudoophthal-
moplegia, I traveled to Scotland, his ancestral home, 
to search for other members of this family. Over a 
period of 40 days, I could not find any but discovered 
unrelated patients with an identical disturbance of 
eye movements. At that time, commercial genetic 
testing for SCA was not yet fully available, and the 
lack of saccades in some patients with ataxia be-
came a "genetic marker" of the disease. The 
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discovery of supranuclear pseudoophthalmoplegia 
remains important but due to its variability can no 
longer be called a genetic marker. The Scottish ex-
perience (Koeppen, et al, 1977) prompted me to ap-
ply to the Alexander-von-Humboldt Foundation for 
a research fellowship. The Foundation agreed, and I 
moved to the University of Hamburg, Germany, 
where I found a warm welcome in the Department 
of Human Genetics and the neuropathological insti-
tute of the Eppendorf University Hospital. The plan 
was to backtrack from autopsy records to surviving 
family members. The director of Eppendorf neuro-
pathology was Prof. Hans-Joachim Colmant, a psy-
chiatrist. He made available a huge archive of neu-
ropathological specimens in the basement of the 
hospital that had survived the bombings of World 
War II. The chief psychiatrist during the war, Prof. 
Hans Bürger-Prinz, decided that the collection of 
slides, reaching back to 1891, should be protected 
against the Allied bombings and moved the collec-
tion to a secure location. Beyond specimens of 
ataxia, the collection also contained invaluable 
other cases, including Jakob's original 1920 speci-
mens of prion disease. It was an exciting experience 
to study these slides and be allowed to make photo-
graphs. German neuropathologists favored Cresyl 
violet as their routine stain, and it was apparent that 
this stain does not properly show the sponginess 
that is readily apparent on hematoxylin-and-eosin. 
My stay in Hamburg was intermittent, but I benefit-
ted from the collection at the Eppendorf Hospital 
over an aggregate period of 2 years. On return to Al-
bany, NY, I began to collect autopsy specimens of 
hereditary ataxia in a tissue repository and, to this 
day, make available fixed and frozen samples to 
other ataxia investigators. 
Another change in direction: From 
dominant to recessive ataxia, 1996-
2021 
After Dr. Massimo Pandolfo and his group dis-
covered the mutation in Friedreich ataxia (FA) in 
1996, my interest changed, and my research now fo-
cuses on this autosomal recessive disease. Though 
FA is a monogenic disease, the pathology offers a 
fascinating array of lesions in multiple organs: brain, 
spinal cord, dorsal root ganglia, sensory peripheral 
nerves, eyes, heart, and the insulin-producing beta 
cells of the pancreas. Many clinicians and FA re-
searchers consider FA a "neurodegenerative" dis-
ease, implying the existence of onset, progression, 
and death. The term neurodegenerative also means 
atrophy, and clinical onset is thought to be related 
to a degree of atrophy that translates to nervous 
system dysfunction. Neuropathologists, however, 
will agree that FA is also a hypoplastic disease as far 
as the spinal cord and dorsal root ganglia are con-
cerned. Sectioning of the spinal cord longitudinally 
to represent dorsal root entry zones as Obersteiner 
and Redlich did in 1894 in Vienna invariably showed 
loss of demarcation between the peripheral nervous 
tissue of dorsal roots and the central nervous tissue 
of the spinal cord (Koeppen, et al, 2017). A surprising 
observation in FA was the protrusion of glial tissue 
from the spinal cord into dorsal roots, in support of 
dysfunction of a local barrier called the boundary 
cap. This work received the 2018 Stout award from 
the United States and Canadian Academy of Pathol-
ogy for “resolving a scientific medical problem by 
studying its anatomic features”. This award is my 
most prized recognition. 
The mystery of brain iron 
In 1967, I participated in the examination of a 
brain that was incrusted by hemosiderin. The diag-
nosis, superficial siderosis, was not difficult, but the 
disorder was thought to be rare, and magnetic reso-
nance imaging with its extraordinary ability to de-
tect brain iron, was still to come. Dr. Kevin D. Barron 
and I studied the specimen in detail, and I entered a 
10-year period of research in normal and pathologi-
cal brain iron (Koeppen et al, 1992-2002). This iron 
work correlated well with my later studies in FA be-
cause other researchers thought that this disease 
was due to iron accumulation in mitochondria of all 
affected organs. 
America, 1964-2021 
My fifty-seven years in the United States con-
stitute two thirds of my life. My early youth was 
troubled by the experience of World War II, America 
has been good to me. I waved goodbye to Europe 
when the Maasdam, a passenger liner of the Hol-
land-America Line put out to sea in late January 
1964, and I greeted the Statue of Liberty 10 days 
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later. I was never homesick, but occasionally think of 
my time as a refugee at the end of World War II. In 
January 1945, my mother packed some essentials 
and took me, two brothers, and a sister by bus to the 
west, leaving the then German province of Silesia. At 
that time, our father was a prisoner of war in an 
American camp near Naples, Italy, and did not re-
turn to Germany until 1947. Things did not stabilize 
until 1949 when the family walked across the border 
between the newly established Communist German 
Democratic Republic and the American zone of West 
Germany. Food, drink, and clothing were scarce, and 
we spent one year in a displaced-persons camp. The 
privations ended in 1950 when the German econ-
omy improved with the outstanding help of the Mar-
shall Plan. After I became more established in the 
United States, I raised a family and met many good 
people. I want to thank my teachers of neurology 
and neuropathology, among whom my friend and 
colleague for 47 years, the late Dr. Kevin D. Barron, 
was the most important (figure 4). The United States 
 
 
Figure 4. Kevin D. Barron and former trainees. From left to right; 
Suhandsu Chokroverty, MBBS; the late Kevin D. Barron, MD, the 
late Cesar Mayo, MD; AHK; and the late Artemio Ordinario, MD. 
The group photo was taken during the combined 1967 meeting 
of the American Association of Neuropathologists and the 
American Neurological Association in Atlantic City, New Jersey. 
 
continues to fascinate me, and, during my Chicago 
years, the sky of the Midwest seemed higher and 
bluer. I did not forget my European origin or my 
years of medical education in Germany. I am still tri-
lingual (English, German, and Spanish) and enjoy the 
occasional opportunity to practice three languages. 
I also became an amateur radio operator (a “ham” 
in American lingo), and my last conversation with my 
late father was by ham radio. While on sabbatical in 
Hamburg, I received the call sign of DJ0RF wherein 
the “DJ0” was reserved for foreign nationals who 
had an amateur radio license in their home coun-
tries. Ham radio will be my main pursuit after I finally 
retire from research or the practice of neurology and 
neuropathology. 
A final word: Do we teach enough clini-
coanatomic correlation? 
We hear a lot from proponents of “evidence-
based” medicine but rarely about the art of medi-
cine. Clinicoanatomic correlation benefits from 
both, and thinking of brain structure while consider-
ing a differential diagnosis is a rewarding exercise. 
Senior physicians will agree that anatomy and pa-
thology are the basis of medicine. Telehealth has ar-
rived and is perhaps not in line with the art of medi-
cine. Its supporters may argue that it is more artful 
than face-to-face and hands-on medicine. Whatever 
we prefer as clinicians, we should strive to empha-
size clinicoanatomic correlation in our teaching and 
convey the joy of a successful diagnosis based on 
traditional knowledge of anatomy. Such thought 
should, of course, precede the ordering of advanced 
imaging. In a recent survey of neurology training 
programs in the United States, 86% of program di-
rectors considered a rotation through neuropathol-
ogy essential (Rayi, et al, 2020). Let me add my voice 
to this goal.
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